These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 16702830)
1. Epidemiology and natural history of multiple sclerosis: new insights. Kantarci O; Wingerchuk D Curr Opin Neurol; 2006 Jun; 19(3):248-54. PubMed ID: 16702830 [TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis: the environment and causation. Giovannoni G; Ebers G Curr Opin Neurol; 2007 Jun; 20(3):261-8. PubMed ID: 17495618 [TBL] [Abstract][Full Text] [Related]
3. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044 [TBL] [Abstract][Full Text] [Related]
4. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Hedström AK; Sundqvist E; Bäärnhielm M; Nordin N; Hillert J; Kockum I; Olsson T; Alfredsson L Brain; 2011 Mar; 134(Pt 3):653-64. PubMed ID: 21303861 [TBL] [Abstract][Full Text] [Related]
5. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis. Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867 [TBL] [Abstract][Full Text] [Related]
6. Genetics and natural history of multiple sclerosis. Kantarci OH Semin Neurol; 2008 Feb; 28(1):7-16. PubMed ID: 18256983 [TBL] [Abstract][Full Text] [Related]
7. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk. Nolan D; Castley A; Tschochner M; James I; Qiu W; Sayer D; Christiansen FT; Witt C; Mastaglia F; Carroll W; Kermode A Neurology; 2012 Aug; 79(6):538-46. PubMed ID: 22786591 [TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: geoepidemiology, genetics and the environment. Milo R; Kahana E Autoimmun Rev; 2010 Mar; 9(5):A387-94. PubMed ID: 19932200 [TBL] [Abstract][Full Text] [Related]
9. Genetic background of multiple sclerosis. Sadovnick AD Autoimmun Rev; 2012 Jan; 11(3):163-6. PubMed ID: 21619948 [TBL] [Abstract][Full Text] [Related]
10. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population. Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364 [TBL] [Abstract][Full Text] [Related]
15. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study. Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D and multiple sclerosis: An update. Pierrot-Deseilligny C; Souberbielle JC Mult Scler Relat Disord; 2017 May; 14():35-45. PubMed ID: 28619429 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561 [TBL] [Abstract][Full Text] [Related]
18. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788 [TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis. Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093 [TBL] [Abstract][Full Text] [Related]
20. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia. Wu JS; James I; Qiu W; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG J Neuroimmunol; 2010 Feb; 219(1-2):109-13. PubMed ID: 20006387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]